Search for: "Eli Lilly " Results 1521 - 1540 of 2,131
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Feb 2010, 3:52 am by sally
Court of Appeal (Criminal Division) Curtis v R [2010] EWCA Crim 123 (09 February 2010) Court of Appeal (Civil Division) O’Beirne v Hudson [2010] EWCA Civ 52 (09 February 2010) Drew v Whitbread [2010] EWCA Civ 53 (09 February 2010) B, R (on the application of) v Cornwall Council & Anor [2010] EWCA Civ 55 (09 February 2010) W (Children), Re [2010] EWCA Civ 57 (09 February 2010) Eli Lilly & Co v Human Genome Sciences Inc [2010] EWCA Civ 33 (09 February 2010) D… [read post]
8 Feb 2010, 9:52 pm by Patent Docs
Eli Lilly and Company v. [read post]
8 Feb 2010, 7:26 pm by Breakstone, White & Gluck
  In 2009, Zyprexra-maker Eli Lilly agreed to pay at least $1.2 billion to similar settle lawsuits filed by about 31,000 patients. [read post]
8 Feb 2010, 10:27 am by Beck, et al.
Zyprexa MDL Plaintiffs' Steering Committee II and Eli Lilly and Co., No. 07-3815-cv (2d Cir. [read post]
7 Feb 2010, 1:01 pm by Michael Baseluos
In a Texas pharmaceutical drug injury and medical malpractice case, a woman sued Eli Lilly claiming that the company's drug warnings were so defective as to contribute to his suicide. [read post]
6 Feb 2010, 5:06 am by Ray Mullman
Lilly agreed to pay $1.4 billion in a related civil settlement. [read post]
2 Feb 2010, 1:02 pm by Carey, Danis & Lowe
The FDA cited that study in its letter informing drug maker Eli Lilly about the label order. [read post]
28 Jan 2010, 2:00 pm by Tom Lamb
FDA has cleared two other treatments for fibromyalgia: Eli Lilly's antidepressant Cymbalta and Pfizer's anti-seizure treatment Lyrica. [read post]
27 Jan 2010, 3:00 am
- ‘indirect consumer tax’ to fund UN public health initiatives (Afro-IP) Canada: Submissions on Canada-EU trade deal: Canadian Generic Pharma Assoc. wants IP out (Michael Geist) Canada: Intellectual property and agriculture – CDC Triffid seed story (ipblog.ca) EU: Records of the 1st, 2nd and 3rd expert meetings on SPCs (The SPC Blog) EU: Cooperation between Board of Appeal and National Court / acceleration of appeal proceedings: Human Genome Sciences v Eli Lilly… [read post]
22 Jan 2010, 12:23 pm by Howard Wasserman
Third, going off something Matt argued: Are businesses (especially large GM/Disney/Eli Lilly types) going to engage in candidate electioneering (as opposed to issue advertising)? [read post]
22 Jan 2010, 5:26 am by Lebowitz & Mzhen
Eli Lilly pleaded guilty to a misdemeanor last January in a nearly $1.5 billion settlement of criminal and civil charges that the pharmaceutical company had marketed Zyprexa, the antipsychotic drug for the treatment of dementia with elderly people. [read post]
19 Jan 2010, 12:00 am
To round out the picture, in a slightly more expected vein (read completely expected) was the Eli Lilly V Actavis (Strattera case). [read post]
13 Jan 2010, 7:00 am by Hopkins
For Eli Lilly, it was print advertisements for its depression drug, Cymbalta. [read post]
13 Jan 2010, 7:00 am by Hopkins
For Eli Lilly, it was print advertisements for its depression drug, Cymbalta. [read post]
13 Jan 2010, 3:00 am
(IP Factor) Netherlands: Court of Appeal, The Hague: Costs of procedure : Lundbeck v Tiefenbacher, Centrafarm Services and Ratiopharm (EPLAW) Poland: First judgment on differences between sponsorship and advertising of pharmaceutical product (Class 46) US: USPTO to begin recalculating patent term following Wyeth v Kappos (Patently-O) (Patent Docs) US: CAFC confirms PTO is miscalculating (undercalculating) delays in prosecution and the corresponding patent term adjustment: Wyeth v Kappos (Patently-O)… [read post]
13 Jan 2010, 2:47 am by Adam Kolber
In 2008 a team led by Heilig reported that an experimental drug called LY686017, made by Eli Lilly, suppressed cravings for alcohol in a small group of recently detoxified alcoholics (Science, vol 319, p 1536). [read post]
12 Jan 2010, 7:26 am by Dennis Crouch
See, for example, Eli Lilly and Co. v. [read post]
10 Jan 2010, 3:53 pm by Levin & Perconti
Last year, Eli Lilly, which markets the drug Zyprexa, paid a $1.4 billion fine and pled guilty to a misdemeanor for promoting its drug to the elderly with dementia. [read post]